IL104305A - History of piperazine, their preparation and pharmaceutical preparations containing them - Google Patents
History of piperazine, their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL104305A IL104305A IL104305A IL10430593A IL104305A IL 104305 A IL104305 A IL 104305A IL 104305 A IL104305 A IL 104305A IL 10430593 A IL10430593 A IL 10430593A IL 104305 A IL104305 A IL 104305A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- compounds
- pct
- phenyl
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929200293A GB9200293D0 (en) | 1992-01-08 | 1992-01-08 | Piperazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
IL104305A0 IL104305A0 (en) | 1993-05-13 |
IL104305A true IL104305A (en) | 1998-04-05 |
Family
ID=10708249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL104305A IL104305A (en) | 1992-01-08 | 1993-01-05 | History of piperazine, their preparation and pharmaceutical preparations containing them |
Country Status (21)
Country | Link |
---|---|
US (1) | US5532242A (de) |
EP (1) | EP0620817B1 (de) |
JP (1) | JP3274865B2 (de) |
KR (1) | KR100283345B1 (de) |
AT (1) | ATE183504T1 (de) |
AU (1) | AU668901B2 (de) |
BR (1) | BR9207030A (de) |
CA (1) | CA2125182A1 (de) |
DE (1) | DE69229834T2 (de) |
ES (1) | ES2134835T3 (de) |
FI (1) | FI106200B (de) |
GB (2) | GB9200293D0 (de) |
HU (1) | HUT70513A (de) |
IL (1) | IL104305A (de) |
MX (1) | MX9300031A (de) |
NZ (1) | NZ246205A (de) |
PH (1) | PH30268A (de) |
RU (1) | RU2128653C1 (de) |
TW (1) | TW265337B (de) |
WO (1) | WO1993014076A1 (de) |
ZA (1) | ZA93141B (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU689762B2 (en) * | 1992-12-21 | 1998-04-09 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
US5451584A (en) * | 1994-11-10 | 1995-09-19 | American Home Products Corporation | N-alkynyl carboxamides as sertonergic agents |
US5541179A (en) * | 1995-05-02 | 1996-07-30 | American Home Products Corporation | Tropon-2-one piperazine carboxamides as serotonergic agents |
ATE229946T1 (de) * | 1996-04-05 | 2003-01-15 | Sod Conseils Rech Applic | Alpha-1 adrenergischer rezeptor antagonisten |
US5610164A (en) * | 1996-07-24 | 1997-03-11 | American Home Products Corporation | (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides |
US6399614B1 (en) | 1997-08-01 | 2002-06-04 | Recordati S.A. Chemical And Pharmaceutical Company | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
IT1293807B1 (it) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
IT1293804B1 (it) | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Diarilalchilpiperazine attive sulle basse vie urinarie |
US6344458B1 (en) | 1998-12-17 | 2002-02-05 | American Home Products Corporation | Piperazine ethylamide derivatives |
WO2000035892A1 (en) * | 1998-12-17 | 2000-06-22 | American Home Products Corporation | Piperazine ethylamide derivatives with 5-ht1a receptor activity |
ES2425114T3 (es) | 2000-03-16 | 2013-10-11 | The Mclean Hospital Corporation | CDP-colina y uridina para el tratamiento del abuso del acohol |
IL153706A0 (en) * | 2000-06-27 | 2003-07-06 | Taisho Pharmaceutical Co Ltd | Therapeutic preparation of anxiety neurosis or depression, and piperazine derivatives |
WO2005122767A1 (en) | 2004-06-10 | 2005-12-29 | Mclean Hospital Corporation | Pyrimidines, such as uridine, in treatments for patients with bipolar disorder |
EP1784199A4 (de) | 2004-08-11 | 2010-06-23 | Mclean Hospital Corp | Verbindungen zur behandlung von marihuana-abhängigkeit, entzug und konsum |
US7731940B2 (en) | 2006-01-25 | 2010-06-08 | The Regents Of The University Of California | Compositions and methods related to serotonin 5-HT1A receptors |
TWI417095B (zh) * | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途 |
TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
CN101801930B (zh) * | 2007-09-14 | 2013-01-30 | 奥梅-杨森制药有限公司 | 1,3-二取代的-4-苯基-1h-吡啶-2-酮 |
JP5366269B2 (ja) | 2007-09-14 | 2013-12-11 | ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 1,3−二置換4−(アリル−x−フェニル)−1h−ピリジン−2−オン |
US9114138B2 (en) | 2007-09-14 | 2015-08-25 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones |
US8785486B2 (en) * | 2007-11-14 | 2014-07-22 | Janssen Pharmaceuticals, Inc. | Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
WO2010025890A1 (en) | 2008-09-02 | 2010-03-11 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
WO2010043396A1 (en) | 2008-10-16 | 2010-04-22 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
WO2010060589A1 (en) | 2008-11-28 | 2010-06-03 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
MX2011011962A (es) | 2009-05-12 | 2012-02-28 | Janssen Pharmaceuticals Inc | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostericos positivos de receptores de glutamato metabotropico (mglur2). |
SG10201402250TA (en) | 2009-05-12 | 2014-07-30 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
WO2011027656A1 (en) | 2009-09-04 | 2011-03-10 | Semiconductor Energy Laboratory Co., Ltd. | Transistor and display device |
WO2012062750A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
EP2643320B1 (de) | 2010-11-08 | 2015-03-04 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridinderivate und ihre verwendung als positiv allosterische modulatoren des mglur2 receptors |
ES2552879T3 (es) | 2010-11-08 | 2015-12-02 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
CN103360342B (zh) * | 2012-04-09 | 2015-12-16 | 江苏恩华药业股份有限公司 | 3-氰基苯胺烷基芳基哌嗪衍生物及在制备药物中的应用 |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
HUE053734T2 (hu) | 2014-01-21 | 2021-07-28 | Janssen Pharmaceutica Nv | 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk |
EA201891617A3 (ru) | 2014-01-21 | 2019-04-30 | Янссен Фармацевтика Нв | Комбинации, содержащие положительные аллостерические модуляторы или ортостерические агонисты метаботропного глутаматергического рецептора 2 подтипа, и их применение |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3037982A (en) * | 1959-08-12 | 1962-06-05 | Miles Lab | Phenylpiperazinylalkyl propionanilides |
AU532411B2 (en) * | 1979-03-01 | 1983-09-29 | Duphar International Research B.V. | Phenyl piperazine derivatives |
NL8005133A (nl) * | 1980-09-12 | 1982-04-01 | Duphar Int Res | Fenylpiperazinederivaten met antiagressieve werking. |
NL8005131A (nl) * | 1980-09-12 | 1982-04-01 | Duphar Int Res | Fenylpiperazinederivaten met analgetische werking. |
EP0185429A1 (de) * | 1984-12-21 | 1986-06-25 | Duphar International Research B.V | Bizyklische Piperazine |
CA1340113C (en) * | 1988-05-24 | 1998-11-03 | Magid A. Abou-Gharbia | Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity |
US5010078A (en) * | 1988-05-24 | 1991-04-23 | American Home Products Corporation | Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity |
GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
US5340812A (en) * | 1989-04-22 | 1994-08-23 | John Wyeth & Brother, Limited | Piperazine derivatives |
IE950248L (en) * | 1989-04-22 | 1990-10-22 | Wyeth John & Brother Ltd | Piperazine derivatives |
FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
DK178590D0 (da) * | 1990-07-26 | 1990-07-26 | Novo Nordisk As | 1,4-disubstituerede piperaziner |
ES2027898A6 (es) * | 1991-01-24 | 1992-06-16 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina. |
-
1992
- 1992-01-08 GB GB929200293A patent/GB9200293D0/en active Pending
- 1992-12-24 JP JP51221993A patent/JP3274865B2/ja not_active Expired - Fee Related
- 1992-12-24 HU HU9402042A patent/HUT70513A/hu not_active IP Right Cessation
- 1992-12-24 AU AU31697/93A patent/AU668901B2/en not_active Ceased
- 1992-12-24 AT AT93900365T patent/ATE183504T1/de not_active IP Right Cessation
- 1992-12-24 RU RU94039542A patent/RU2128653C1/ru active
- 1992-12-24 BR BR9207030A patent/BR9207030A/pt not_active Application Discontinuation
- 1992-12-24 NZ NZ246205A patent/NZ246205A/en unknown
- 1992-12-24 GB GB9227001A patent/GB2263110B/en not_active Expired - Fee Related
- 1992-12-24 ES ES93900365T patent/ES2134835T3/es not_active Expired - Lifetime
- 1992-12-24 CA CA002125182A patent/CA2125182A1/en not_active Abandoned
- 1992-12-24 WO PCT/GB1992/002399 patent/WO1993014076A1/en active IP Right Grant
- 1992-12-24 DE DE69229834T patent/DE69229834T2/de not_active Expired - Fee Related
- 1992-12-24 KR KR1019940702344A patent/KR100283345B1/ko not_active IP Right Cessation
- 1992-12-24 US US08/256,330 patent/US5532242A/en not_active Expired - Lifetime
- 1992-12-24 EP EP93900365A patent/EP0620817B1/de not_active Expired - Lifetime
-
1993
- 1993-01-05 IL IL104305A patent/IL104305A/en not_active IP Right Cessation
- 1993-01-06 TW TW082100059A patent/TW265337B/zh active
- 1993-01-07 PH PH45533A patent/PH30268A/en unknown
- 1993-01-07 MX MX9300031A patent/MX9300031A/es not_active IP Right Cessation
- 1993-01-08 ZA ZA93141A patent/ZA93141B/xx unknown
-
1994
- 1994-07-07 FI FI943247A patent/FI106200B/fi active
Also Published As
Publication number | Publication date |
---|---|
EP0620817A1 (de) | 1994-10-26 |
GB2263110A (en) | 1993-07-14 |
MX9300031A (es) | 1993-07-01 |
JP3274865B2 (ja) | 2002-04-15 |
JPH07502739A (ja) | 1995-03-23 |
ATE183504T1 (de) | 1999-09-15 |
NZ246205A (en) | 1996-12-20 |
BR9207030A (pt) | 1995-12-05 |
DE69229834T2 (de) | 2000-01-13 |
HU9402042D0 (en) | 1994-09-28 |
RU2128653C1 (ru) | 1999-04-10 |
GB9227001D0 (en) | 1993-02-17 |
IL104305A0 (en) | 1993-05-13 |
AU3169793A (en) | 1993-08-03 |
HUT70513A (en) | 1995-10-30 |
ES2134835T3 (es) | 1999-10-16 |
EP0620817B1 (de) | 1999-08-18 |
AU668901B2 (en) | 1996-05-23 |
GB9200293D0 (en) | 1992-02-26 |
RU94039542A (ru) | 1996-08-10 |
DE69229834D1 (de) | 1999-09-23 |
FI106200B (fi) | 2000-12-15 |
WO1993014076A1 (en) | 1993-07-22 |
KR100283345B1 (ko) | 2001-03-02 |
CA2125182A1 (en) | 1993-07-22 |
GB2263110B (en) | 1995-08-09 |
PH30268A (en) | 1997-02-20 |
FI943247A0 (fi) | 1994-07-07 |
US5532242A (en) | 1996-07-02 |
TW265337B (de) | 1995-12-11 |
ZA93141B (en) | 1994-07-08 |
FI943247A (fi) | 1994-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5532242A (en) | Piperazine derivatives as 5-HT receptors antagonists | |
US5710149A (en) | Piperazine derivatives as 5-ht antagonists | |
SK280133B6 (sk) | Piperazínové deriváty, spôsob ich výroby, farmaceu | |
HUT54666A (en) | Process for producing peperazine derivatives and pharmaceutical compositions containing them | |
US5430033A (en) | Piperazine derivatives | |
US5627177A (en) | Piperazine derivatives | |
US5340812A (en) | Piperazine derivatives | |
AU642044B2 (en) | Piperazine derivatives | |
US5629323A (en) | Amide derivatives as 5-HT1A ligands | |
US5585374A (en) | Amide derivatives | |
US5420278A (en) | ω-(4-aryl or heteroarylpiperazine-1-yl)-2-aryl or aralkyl-propanoic or butanoic acids | |
US5519025A (en) | 4-indolylpiperazinyl derivatives | |
US5541326A (en) | Piperazine Derivatives | |
EP0782574B1 (de) | Bicyclische carboxamide als 5-ht1a rezeptoren liganden | |
EP0687257B1 (de) | 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten | |
Cliffe et al. | Amide derivatives as 5-HT 1A ligands | |
SK279528B6 (sk) | Uticképrostriedky s ich obsahom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
RH1 | Patent not in force |